Table: SymBio Pharmaceuticals - 9-MTH group results

SymBio Pharmaceuticals

31/10/2024 06:30

Oct 31 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Sep 30, 2024        Sep 30, 2023      Dec 31, 2024  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             1.90                4.42              2.62      
                 (-57.1 pct)         (-39.9 pct)       (-53.1 pct)  
  Operating       loss 2.79         loss 283 mln        loss 3.70   
  Recurring       loss 2.76         loss 156 mln        loss 3.52   
  Net             loss 2.85         loss 788 mln        loss 3.63   
  EPS          loss 63.43 yen      loss 19.89 yen    loss 84.15 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T